These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 29189159)
1. Oncorine, the World First Oncolytic Virus Medicine and its Update in China. Liang M Curr Cancer Drug Targets; 2018; 18(2):171-176. PubMed ID: 29189159 [TBL] [Abstract][Full Text] [Related]
2. Clinical development of oncolytic viruses in China. Liang M Curr Pharm Biotechnol; 2012 Jul; 13(9):1852-7. PubMed ID: 21740357 [TBL] [Abstract][Full Text] [Related]
3. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China. Wei D; Xu J; Liu XY; Chen ZN; Bian H Hum Gene Ther; 2018 Feb; 29(2):151-159. PubMed ID: 29284308 [TBL] [Abstract][Full Text] [Related]
4. Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans. Cerullo V; Koski A; Vähä-Koskela M; Hemminki A Adv Cancer Res; 2012; 115():265-318. PubMed ID: 23021247 [TBL] [Abstract][Full Text] [Related]
5. Regulatory aspects of oncolytic virus products. Yamaguchi T; Uchida E Curr Cancer Drug Targets; 2007 Mar; 7(2):203-8. PubMed ID: 17346112 [TBL] [Abstract][Full Text] [Related]
6. Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies. Yamaguchi T; Uchida E Curr Cancer Drug Targets; 2018; 18(2):202-208. PubMed ID: 28228083 [TBL] [Abstract][Full Text] [Related]
7. Clinical trials with oncolytic adenovirus in China. Yu W; Fang H Curr Cancer Drug Targets; 2007 Mar; 7(2):141-8. PubMed ID: 17346105 [TBL] [Abstract][Full Text] [Related]
8. Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics. Harrington KJ; Vile RG; Melcher A; Chester J; Pandha HS Cytokine Growth Factor Rev; 2010; 21(2-3):91-8. PubMed ID: 20223697 [TBL] [Abstract][Full Text] [Related]
9. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses. Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547 [TBL] [Abstract][Full Text] [Related]
10. Oncolytic Virotherapy by HSV. Watanabe D; Goshima F Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663 [TBL] [Abstract][Full Text] [Related]
11. Virus combinations and chemotherapy for the treatment of human cancers. Kumar S; Gao L; Yeagy B; Reid T Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102 [TBL] [Abstract][Full Text] [Related]
12. Editorial: Oncolytic Virus and Gene Thearapy Application: Update 2018. Abei M Curr Cancer Drug Targets; 2018; 18(2):108. PubMed ID: 29457568 [No Abstract] [Full Text] [Related]
14. Oncolytic Viruses: The Best is Yet to Come. Lemay CG; Keller BA; Edge RE; Abei M; Bell JC Curr Cancer Drug Targets; 2018; 18(2):109-123. PubMed ID: 28176648 [TBL] [Abstract][Full Text] [Related]
15. Advance in herpes simplex viruses for cancer therapy. Liu S; Dai M; You L; Zhao Y Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy progress and prospects cancer: oncolytic viruses. Liu TC; Kirn D Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413 [TBL] [Abstract][Full Text] [Related]
17. Oncolytic virus preclinical toxicology studies. Rasa A; Alberts P J Appl Toxicol; 2023 May; 43(5):620-648. PubMed ID: 36299168 [TBL] [Abstract][Full Text] [Related]
18. United virus: the oncolytic tag-team against cancer! Le Boeuf F; Bell JC Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326 [TBL] [Abstract][Full Text] [Related]
19. Recent advances of oncolytic virus in cancer therapy. Mondal M; Guo J; He P; Zhou D Hum Vaccin Immunother; 2020 Oct; 16(10):2389-2402. PubMed ID: 32078405 [TBL] [Abstract][Full Text] [Related]
20. Designer nanocarriers for navigating the systemic delivery of oncolytic viruses. Howard F; Muthana M Nanomedicine (Lond); 2020 Jan; 15(1):93-110. PubMed ID: 31868115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]